Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.
Mortality of patients with multiple sclerosis: a cohort study in UK primary care.
Gut commensalism, cytokines, and central nervous system demyelination.
Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis.
Using mental visual imagery to improve autobiographical memory and episodic future thinking in relapsing-remitting multiple sclerosis patients: A randomised-controlled trial study.
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression.
Plasma Exchange and Immunoadsorption in Pediatric Inflammatory Optic Neuropathy Resistant to Corticosteroid Therapy: Four French Cases.
Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses.
Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.
Schwann cells-axon interaction in myelination.
An update of teriflunomide for treatment of multiple sclerosis.
Outcomes After Early Administration of Plasma Exchange in Pediatric Central Nervous System Inflammatory Demyelination.
Nurse-led clinics for patients with chronic diseases in hospital and transmural care organizations.
Disease exacerbation after rituximab induction in neuromyelitis optica.
Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.
Symptoms of multiple sclerosis during use of combined hormonal contraception.
Aquaporin-1 Antibody in Neuromyelitis Optica Patients.
Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases.
Association between perceived fatigue and gait parameters measured by an instrumented treadmill in people with multiple sclerosis: a cross-sectional study.
TLR2 Stimulation Regulates the Balance between Regulatory T Cell and Th17 Function: A Novel Mechanism of Reduced Regulatory T Cell Function in Multiple Sclerosis.
The Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Multiple Sclerosis.
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.
A pilot study examining functional brain activity 6 months after memory retraining in MS: the MEMREHAB trial.
Association between OSA and Severe Fatigue in Patients with Multiple Sclerosis (MS).
Pages
« first
‹ previous
…
667
668
669
670
671
672
673
674
675
…
next ›
last »